BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6452881)

  • 1. [Symptomatic therapy in a possible animal model for Huntington's chorea].
    Schneider G; Oepen H; Klapproth A
    Arzneimittelforschung; 1981; 31(3):437-41. PubMed ID: 6452881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the effect of the neurolathyrogenic substance beta,beta'-iminodipropionitrile on the branchiopode Artemia salina (author's transl)].
    Schneider G; Rüther W; Klapproth A; Schott KJ
    Arzneimittelforschung; 1980; 30(4):592-3. PubMed ID: 7190398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Huntington's chorea with bromocriptine.
    Frattola L; Albiazzati MG; Spano PF; Trabucchi M
    Acta Neurol Scand; 1977 Jul; 56(1):37-45. PubMed ID: 141860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease.
    Casaca-Carreira J; Temel Y; van Zelst M; Jahanshahi A
    Behav Neurol; 2015; 2015():970204. PubMed ID: 26063966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine and Huntington's chorea.
    Frattola L; Albizzatir MG; Trabucchi M
    Arch Neurol; 1978 Jan; 35(1):60. PubMed ID: 145841
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
    Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
    Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid and Huntington's chorea.
    Roccatagliata G; Albano C
    N Engl J Med; 1978 Feb; 298(8):457. PubMed ID: 146161
    [No Abstract]   [Full Text] [Related]  

  • 9. [Attempted direct etiological treatment of Huntington's chorea. Case reports].
    Majeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
    Minerva Med; 1980 Apr; 71(16):1213-20. PubMed ID: 6445524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid and Huntington's chorea.
    Perry TL
    N Engl J Med; 1978 May; 298(19):1092-3. PubMed ID: 148007
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Huntington's chorea with isoniazid.
    Perry TL; MacLeod PM; Hansen S
    N Engl J Med; 1977 Oct; 297(15):840. PubMed ID: 142923
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of beta,beta'-iminodipropionitrile (IDPN) in the domestic fowl (Gallus domesticus).
    Sokomba E; Osuide G
    Gen Pharmacol; 1984; 15(3):211-5. PubMed ID: 6735135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bromocriptine in Huntington chorea. Case report.
    Tsuneizumi T; Anai K; Aoba A; Yamaguchi N; Takagi H; Chishima T; Sakai T; Negishi K; Kamimura M; Takeshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):823-9. PubMed ID: 7938569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior characterization of a model of Huntington's disease in rats, induced by quinolinic acid].
    Francis L; Cruz R; Antúnez I; Rosillo JC
    Rev Neurol; 2000 Jun 1-15; 30(11):1016-21. PubMed ID: 10904945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kainic acid animal model predicts therapeutic agents in Huntington's chorea.
    Borison RL; Diamond BI
    Trans Am Neurol Assoc; 1979; 104():67-9. PubMed ID: 162258
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative evaluation of functional capacity during isoniazid therapy in Huntington's disease.
    Stober T; Schimrigk K; Holzer G; Ziegler B
    J Neurol; 1983; 229(4):237-45. PubMed ID: 6192225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel.
    Cao C; Temel Y; Blokland A; Ozen H; Steinbusch HW; Vlamings R; Nguyen HP; von Hörsten S; Schmitz C; Visser-Vandewalle V
    Behav Brain Res; 2006 Jun; 170(2):257-61. PubMed ID: 16569446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional neurochemical studies on the effect of beta, beta'-iminodipropionitrile (IDPN) in the rat.
    Langlais PJ; Huang PC; Gabay S
    J Neurosci Res; 1975; 1(5-6):419-35. PubMed ID: 1241588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.